More than 300 million people live with asthma globally, and 6 million do not adequately control their symptoms. In a new European survey of nearly 1,000 severe asthma patients, 88% reported the condition impacted their daily lives, and almost the same amount (84%) said asthma limited their physical activity.
Jay Bradner, President of the Novartis Institutes for BioMedical Research (NIBR) and Vas Narasimhan, Head of Global Drug Development and Chief Medical Officer, share their outlook for innovation in 2017.
The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.
